secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001683168-25-007478
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Amy Trombly amends employment agreement; COO Bruce Thornton retires, position eliminated
--------------------------------------------------------------------------------

- CEO Amy Trombly's base salary set at $475,000 per annum; target annual bonus of 50% of base salary.
- CEO severance: termination without cause or for Good Reason: 1x base salary paid via payroll; COBRA up to 12 months.
- CEO change-in-control severance: 2x base salary + 2x target bonus; COBRA up to 24 months.
- COO Bruce Thornton to retire on Dec 2, 2025; position eliminated; severance $300,000 plus COBRA up to 12 months.
- COO's time-based equity awards fully vest; performance-based awards remain per terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825007478/0001683168-25-007478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825007478/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-007478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer